drugset / Trial / NCT00402012

"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM

NCT00402012

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to look at the effect of Pioglitazone treatment on the body's ability to burn food in order to produce energy.

Timeline

Start
2006-11
Primary completion
2007-12
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule 30 mg
Subject Pioglitazone Small molecule 45 mg